Xc. Yu et al., LOCALIZATION OF CELL-DIVISION PROTEIN FTSK TO THE ESCHERICHIA-COLI SEPTUM AND IDENTIFICATION OF A POTENTIAL N-TERMINAL TARGETING DOMAIN, Journal of bacteriology, 180(5), 1998, pp. 1296-1304
Escherichia coli cell division protein FtsK is a homolog of Bacillus s
ubtilis SpoIIIE and appears to act late in the septation process, Td d
etermine whether FtsK localizes to the septum, we fused three N-termin
al segments of FtsK to green fluorescent protein (GFP) and expressed t
hem in E. coli cells, All three segments were sufficient to target GFP
to the septum, suggesting that as little as the first 15% of the prot
ein is a septum-targeting domain. Localized fluorescence was detectabl
e only in cells containing a visible midcell constriction, suggesting
that FtsK targeting normally occurs only at a late stage of septation,
The largest two FtsK-GFP fusions were able at least partially to comp
lement the ftsK44 mutation in trans, suggesting that the N- and C-term
inal domains are functionally separable However, overproduction of Fts
K-GFP resulted in a late-septation phenotype similar to that of ftsK44
, with fluorescent dots localized at the blocked septa, suggesting tha
t high levels of the N-terminal domain mag; still localize but also in
hibit FtsK activity., interestingly, under these conditions fluorescen
ce was also sometimes localized as hands at potential division sites,
suggesting that FtsK-GFP is capable of targeting very early. In additi
on, FtsK-GFP localized to potential division sites in cephalexim-induc
ed and ftsI mutant filaments, further supporting the idea that FtsK-GF
P fan target early, perhaps by recognizing FtsZ directly. This hypothe
sis was supported by the failure of FtsK-GFP to localize in ftsZ mutan
t filaments, In ftsK44 mutant filaments, FtsA and FtsZ were usually lo
calized to potential division sites between the blocked septa. When th
e ftsK44 mutation was incorporated into the Ftsk-GFP fusions, localiza
tion to midcell ranged between very weak and undetectable, suggesting
that the FtsK44 mutant protein is defective in targeting the septum.